Skip to main content

Developing aptamers into therapeutics.

Publication ,  Journal Article
White, RR; Sullenger, BA; Rusconi, CP
Published in: J Clin Invest
October 2000

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Invest

DOI

ISSN

0021-9738

Publication Date

October 2000

Volume

106

Issue

8

Start / End Page

929 / 934

Location

United States

Related Subject Headings

  • Tunica Intima
  • Technology, Pharmaceutical
  • Oligonucleotides
  • Nucleic Acids
  • Neovascularization, Physiologic
  • Immunology
  • Drug Design
  • Combinatorial Chemistry Techniques
  • Blood Coagulation
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
White, R. R., Sullenger, B. A., & Rusconi, C. P. (2000). Developing aptamers into therapeutics. J Clin Invest, 106(8), 929–934. https://doi.org/10.1172/JCI11325
White, R. R., B. A. Sullenger, and C. P. Rusconi. “Developing aptamers into therapeutics.J Clin Invest 106, no. 8 (October 2000): 929–34. https://doi.org/10.1172/JCI11325.
White RR, Sullenger BA, Rusconi CP. Developing aptamers into therapeutics. J Clin Invest. 2000 Oct;106(8):929–34.
White, R. R., et al. “Developing aptamers into therapeutics.J Clin Invest, vol. 106, no. 8, Oct. 2000, pp. 929–34. Pubmed, doi:10.1172/JCI11325.
White RR, Sullenger BA, Rusconi CP. Developing aptamers into therapeutics. J Clin Invest. 2000 Oct;106(8):929–934.

Published In

J Clin Invest

DOI

ISSN

0021-9738

Publication Date

October 2000

Volume

106

Issue

8

Start / End Page

929 / 934

Location

United States

Related Subject Headings

  • Tunica Intima
  • Technology, Pharmaceutical
  • Oligonucleotides
  • Nucleic Acids
  • Neovascularization, Physiologic
  • Immunology
  • Drug Design
  • Combinatorial Chemistry Techniques
  • Blood Coagulation
  • 42 Health sciences